Skip to main navigation

Our Science
- How PEPs™ Work
- Development Programs
Platform
- Our Pipeline
Patients
About Us
Investors
Careers
Contact Us

Biography

Annabel Samimy

Stifel

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives. MBX is advancing a pipeline of PEPs for clinically validated targets designed to deliver superior pharmaceutical properties and overcome key limitations of native peptide therapeutics.

FOLLOW US

©2026 MBX Bio. All Rights Reserved.

Contact Us
Privacy Policy
Terms of Use

Website design by Mentus

©2026 MBX Bio. All Rights Reserved.

Website design by Mentus